Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Brain Region-Specific nAChR and Associated Protein Abundance Alterations Following Chronic Nicotine and/or Menthol Exposure.

Mulcahy MJ, Huard SM, Paulo JA, Wang JH, McKinney S, Henderson BJ, Lester HA.

J Proteome Res. 2019 Oct 28. doi: 10.1021/acs.jproteome.9b00286. [Epub ahead of print]

PMID:
31657575
2.

Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.

Avelar AJ, Akers AT, Baumgard ZJ, Cooper SY, Casinelli GP, Henderson BJ.

Neuropharmacology. 2019 Nov 1;158:107729. doi: 10.1016/j.neuropharm.2019.107729. Epub 2019 Jul 29.

3.

Brain Region Specific Single-Molecule Fluorescence Imaging.

Fu X, Moonschi FH, Fox-Loe AM, Snell AA, Hopkins DM, Avelar AJ, Henderson BJ, Pauly JR, Richards CI.

Anal Chem. 2019 Aug 6;91(15):10125-10131. doi: 10.1021/acs.analchem.9b02133. Epub 2019 Jul 24.

PMID:
31298524
4.

Chronic Menthol Does Not Change Stoichiometry or Functional Plasma Membrane Levels of Mouse α3β4-Containing Nicotinic Acetylcholine Receptors.

Bavan S, Kim CH, Henderson BJ, Lester HA.

Mol Pharmacol. 2019 Apr;95(4):398-407. doi: 10.1124/mol.118.114769. Epub 2019 Jan 22.

PMID:
30670481
5.

Menthol Stereoisomers Exhibit Different Effects on α4β2 nAChR Upregulation and Dopamine Neuron Spontaneous Firing.

Henderson BJ, Grant S, Chu BW, Shahoei R, Huard SM, Saladi SSM, Tajkhorshid E, Dougherty DA, Lester HA.

eNeuro. 2019 Jan 4;5(6). pii: ENEURO.0465-18.2018. doi: 10.1523/ENEURO.0465-18.2018. eCollection 2018 Nov-Dec.

6.

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Wall TR, Henderson BJ, Voren G, Wageman CR, Deshpande P, Cohen BN, Grady SR, Marks MJ, Yohannes D, Kenny PJ, Bencherif M, Lester HA.

Front Pharmacol. 2017 Sep 26;8:641. doi: 10.3389/fphar.2017.00641. eCollection 2017.

7.

Menthol Enhances Nicotine Reward-Related Behavior by Potentiating Nicotine-Induced Changes in nAChR Function, nAChR Upregulation, and DA Neuron Excitability.

Henderson BJ, Wall TR, Henley BM, Kim CH, McKinney S, Lester HA.

Neuropsychopharmacology. 2017 Nov;42(12):2285-2291. doi: 10.1038/npp.2017.72. Epub 2017 Apr 2.

8.

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking.

Fox-Loe AM, Henderson BJ, Richards CI.

J Vis Exp. 2017 Mar 16;(121). doi: 10.3791/55466.

9.

Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.

Nichols WA, Henderson BJ, Marotta CB, Yu CY, Richards C, Dougherty DA, Lester HA, Cohen BN.

PLoS One. 2016 Jun 23;11(6):e0158032. doi: 10.1371/journal.pone.0158032. eCollection 2016.

10.

Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Henderson BJ, Wall TR, Henley BM, Kim CH, Nichols WA, Moaddel R, Xiao C, Lester HA.

J Neurosci. 2016 Mar 9;36(10):2957-74. doi: 10.1523/JNEUROSCI.4194-15.2016.

11.

Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons.

Srinivasan R, Henley BM, Henderson BJ, Indersmitten T, Cohen BN, Kim CH, McKinney S, Deshpande P, Xiao C, Lester HA.

J Neurosci. 2016 Jan 6;36(1):65-79. doi: 10.1523/JNEUROSCI.2126-15.2016.

12.

Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.

Xiao C, Miwa JM, Henderson BJ, Wang Y, Deshpande P, McKinney SL, Lester HA.

J Neurosci. 2015 Mar 4;35(9):3734-46. doi: 10.1523/JNEUROSCI.3528-14.2015.

13.

Inside-out neuropharmacology of nicotinic drugs.

Henderson BJ, Lester HA.

Neuropharmacology. 2015 Sep;96(Pt B):178-93. doi: 10.1016/j.neuropharm.2015.01.022. Epub 2015 Feb 4. Review.

14.

Lynx1 shifts α4β2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum.

Nichols WA, Henderson BJ, Yu C, Parker RL, Richards CI, Lester HA, Miwa JM.

J Biol Chem. 2014 Nov 7;289(45):31423-32. doi: 10.1074/jbc.M114.573667. Epub 2014 Sep 5.

15.

Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease.

Srinivasan R, Henderson BJ, Lester HA, Richards CI.

Pharmacol Res. 2014 May;83:20-9. doi: 10.1016/j.phrs.2014.02.005. Epub 2014 Mar 1. Review.

16.

Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors.

Henderson BJ, Srinivasan R, Nichols WA, Dilworth CN, Gutierrez DF, Mackey ED, McKinney S, Drenan RM, Richards CI, Lester HA.

J Gen Physiol. 2014 Jan;143(1):51-66. doi: 10.1085/jgp.201311102.

17.

Discovery of benzamide analogs as negative allosteric modulators of human neuronal nicotinic receptors: pharmacophore modeling and structure-activity relationship studies.

Yi B, Long S, González-Cestari TF, Henderson BJ, Pavlovicz RE, Werbovetz K, Li C, McKay DB.

Bioorg Med Chem. 2013 Aug 1;21(15):4730-43. doi: 10.1016/j.bmc.2013.03.082. Epub 2013 Apr 6.

18.

Defining the putative inhibitory site for a selective negative allosteric modulator of human α4β2 neuronal nicotinic receptors.

Henderson BJ, González-Cestari TF, Yi B, Pavlovicz RE, Boyd RT, Li C, Bergmeier SC, McKay DB.

ACS Chem Neurosci. 2012 Sep 19;3(9):682-92. Epub 2012 May 25.

19.

3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors.

Henderson BJ, Orac CM, Maciagiewicz I, Bergmeier SC, McKay DB.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1797-813. doi: 10.1016/j.bmcl.2011.11.051. Epub 2011 Nov 20.

20.

Discovery of Novel α4β2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening.

Mahasenan KV, Pavlovicz RE, Henderson BJ, González-Cestari TF, Yi B, McKay DB, Li C.

ACS Med Chem Lett. 2011 Sep 18;2(11):855-60. doi: 10.1021/ml2001714. eCollection 2011 Nov 10.

Supplemental Content

Loading ...
Support Center